Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Oral Drugs for Benign Prostatic Hyperplasia Supply, Demand and Key Producers, 2024-2030

date 25 Feb 2024

date Pharma & Healthcare

new_biaoQian Oral Drugs for Benign Prostatic Hyperplasia

The global Oral Drugs for Benign Prostatic Hyperplasia market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Oral Drugs for Benign Prostatic Hyperplasia Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 05 Jan 2024

date Pharma & Healthcare

new_biaoQian Oral Drugs for Benign Prostatic Hyperplasia

According to our (Global Info Research) latest study, the global Oral Drugs for Benign Prostatic Hyperplasia market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Oral Drugs for Benign Prostatic Hyperplasia Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Pharma & Healthcare

new_biaoQian Oral Drugs for Benign Prostatic Hyperplasia

BPH is an enlarged prostate. The prostate goes through two main growth cycles during a man’s life. The first occurs early in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this second growth phase.

USD3480.00

Add To Cart

Add To Cart

Global Oral Drugs for Benign Prostatic Hyperplasia Supply, Demand and Key Producers, 2023-2029

date 04 Feb 2023

date Pharma & Healthcare

new_biaoQian Oral Drugs for Benign Prostatic Hyperplasia

The global Oral Drugs for Benign Prostatic Hyperplasia market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

industry 25 Feb 2024

industry Pharma & Healthcare

new_biaoQian Oral Drugs for Benign Prostatic Hyperplasia

The global Oral Drugs for Benign Prostatic Hyperplasia market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 05 Jan 2024

industry Pharma & Healthcare

new_biaoQian Oral Drugs for Benign Prostatic Hyperplasia

According to our (Global Info Research) latest study, the global Oral Drugs for Benign Prostatic Hyperplasia market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 06 Feb 2023

industry Pharma & Healthcare

new_biaoQian Oral Drugs for Benign Prostatic Hyperplasia

BPH is an enlarged prostate. The prostate goes through two main growth cycles during a man’s life. The first occurs early in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this second growth phase.

USD3480.00

addToCart

Add To Cart

industry 04 Feb 2023

industry Pharma & Healthcare

new_biaoQian Oral Drugs for Benign Prostatic Hyperplasia

The global Oral Drugs for Benign Prostatic Hyperplasia market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart